Table 2 Distribution of new bone formation and fibrosis grades in the study groups at study intervals
Histologic events | Study groups | Intensity of reaction | Experimental periods | |||
|---|---|---|---|---|---|---|
7 days | 30 days | 60 days | 90 days | |||
New Bone Formation | MTA (%) | Severe | 0 | 30 | 70 | 100 |
Moderate | 70 | 70 | 30 | 0 | ||
Mild | 30 | 0 | 0 | 0 | ||
None | 0 | 0 | 0 | 0 | ||
MTA-ABS (%) | Severe | 0 | 20 | 60 | 100 | |
Moderate | 60 | 80 | 40 | 0 | ||
Mild | 40 | 0 | 0 | 0 | ||
None | 0 | 0 | 0 | 0 | ||
Control (%) | Severe | 0 | 50 | 25 | 100 | |
Moderate | 12.5 | 37.5 | 75 | 0 | ||
Mild | 87.5 | 12.5 | 0 | 0 | ||
None | 0 | 0 | 0 | 0 | ||
Fibrosis | MTA (%) | Severe | 0 | 0 | 0 | 0 |
Moderate | 0 | 0 | 0 | 0 | ||
Mild | 100 | 70 | 10 | 20 | ||
None | 0 | 0 | 0 | 0 | ||
MTA-ABS (%) | Severe | 0 | 0 | 0 | 0 | |
Moderate | 40 | 0 | 10 | 0 | ||
Mild | 60 | 40 | 0 | 50 | ||
None | 0 | 0 | 0 | 0 | ||
Control (%) | Severe | 0 | 0 | 0 | 0 | |
Moderate | 25 | 0 | 0 | 0 | ||
Mild | 75 | 37.5 | 25 | 75 | ||
None | 0 | 0 | 0 | 0 | ||